496 related articles for article (PubMed ID: 25278115)
1. New multiple sclerosis phenotypic classification.
Lublin FD
Eur Neurol; 2014; 72 Suppl 1():1-5. PubMed ID: 25278115
[TBL] [Abstract][Full Text] [Related]
2. Management of worsening multiple sclerosis with mitoxantrone: a review.
Fox EJ
Clin Ther; 2006 Apr; 28(4):461-74. PubMed ID: 16750460
[TBL] [Abstract][Full Text] [Related]
3. Natural history of multiple sclerosis: a unifying concept.
Confavreux C; Vukusic S
Brain; 2006 Mar; 129(Pt 3):606-16. PubMed ID: 16415308
[TBL] [Abstract][Full Text] [Related]
4. Cognitive reserve and symptom experience in multiple sclerosis: a buffer to disability progression over time?
Schwartz CE; Quaranto BR; Healy BC; Benedict RH; Vollmer TL
Arch Phys Med Rehabil; 2013 Oct; 94(10):1971-81. PubMed ID: 23727344
[TBL] [Abstract][Full Text] [Related]
5. MRI as an outcome in multiple sclerosis clinical trials.
Daumer M; Neuhaus A; Morrissey S; Hintzen R; Ebers GC
Neurology; 2009 Feb; 72(8):705-11. PubMed ID: 19073945
[TBL] [Abstract][Full Text] [Related]
6. A comparison of memory performance in relapsing-remitting, primary progressive and secondary progressive, multiple sclerosis.
Gaudino EA; Chiaravalloti ND; DeLuca J; Diamond BJ
Neuropsychiatry Neuropsychol Behav Neurol; 2001 Jan; 14(1):32-44. PubMed ID: 11234907
[TBL] [Abstract][Full Text] [Related]
7. [Overview of the clinical forms of multiple sclerosis in Japan].
Fukazawa T
Rinsho Shinkeigaku; 2002 Nov; 42(11):1192-4. PubMed ID: 12784703
[TBL] [Abstract][Full Text] [Related]
8. Classification, diagnosis, and differential diagnosis of multiple sclerosis.
Katz Sand I
Curr Opin Neurol; 2015 Jun; 28(3):193-205. PubMed ID: 25887774
[TBL] [Abstract][Full Text] [Related]
9. Relapses and progression of disability in multiple sclerosis.
Confavreux C; Vukusic S; Moreau T; Adeleine P
N Engl J Med; 2000 Nov; 343(20):1430-8. PubMed ID: 11078767
[TBL] [Abstract][Full Text] [Related]
10. Primary progressive multiple sclerosis: part of the MS disease spectrum or separate disease entity?
Antel J; Antel S; Caramanos Z; Arnold DL; Kuhlmann T
Acta Neuropathol; 2012 May; 123(5):627-38. PubMed ID: 22327362
[TBL] [Abstract][Full Text] [Related]
11. Primary progressive multiple sclerosis: a distinct syndrome?
McDonnell GV; Hawkins SA
Mult Scler; 1996 Oct; 2(3):137-41. PubMed ID: 9345378
[TBL] [Abstract][Full Text] [Related]
12. Defining the clinical course of multiple sclerosis: the 2013 revisions.
Lublin FD; Reingold SC; Cohen JA; Cutter GR; Sørensen PS; Thompson AJ; Wolinsky JS; Balcer LJ; Banwell B; Barkhof F; Bebo B; Calabresi PA; Clanet M; Comi G; Fox RJ; Freedman MS; Goodman AD; Inglese M; Kappos L; Kieseier BC; Lincoln JA; Lubetzki C; Miller AE; Montalban X; O'Connor PW; Petkau J; Pozzilli C; Rudick RA; Sormani MP; Stüve O; Waubant E; Polman CH
Neurology; 2014 Jul; 83(3):278-86. PubMed ID: 24871874
[TBL] [Abstract][Full Text] [Related]
13. The changing clinical course of multiple sclerosis: a matter of gray matter.
Calabrese M; Romualdi C; Poretto V; Favaretto A; Morra A; Rinaldi F; Perini P; Gallo P
Ann Neurol; 2013 Jul; 74(1):76-83. PubMed ID: 23494723
[TBL] [Abstract][Full Text] [Related]
14. [Multiple sclerosis without treatment: characteristic features of 70 untreated patients in a cohort of 1187 patients].
Sekkat Z; Ongagna JC; Collongues N; Fleury M; Blanc F; de Seze J;
Rev Neurol (Paris); 2012 Apr; 168(4):338-43. PubMed ID: 22341991
[TBL] [Abstract][Full Text] [Related]
15. The clinical course of multiple sclerosis.
Confavreux C; Vukusic S
Handb Clin Neurol; 2014; 122():343-69. PubMed ID: 24507525
[TBL] [Abstract][Full Text] [Related]
16. Disability as an outcome in MS clinical trials.
Ebers GC; Heigenhauser L; Daumer M; Lederer C; Noseworthy JH
Neurology; 2008 Aug; 71(9):624-31. PubMed ID: 18480462
[TBL] [Abstract][Full Text] [Related]
17. Relapsing-remitting multiple sclerosis: sequential enhanced MR imaging vs clinical findings in determining disease activity.
Barkhof F; Scheltens P; Frequin ST; Nauta JJ; Tas MW; Valk J; Hommes OR
AJR Am J Roentgenol; 1992 Nov; 159(5):1041-7. PubMed ID: 1414773
[TBL] [Abstract][Full Text] [Related]
18. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force.
Miller DH; Albert PS; Barkhof F; Francis G; Frank JA; Hodgkinson S; Lublin FD; Paty DW; Reingold SC; Simon J
Ann Neurol; 1996 Jan; 39(1):6-16. PubMed ID: 8572668
[TBL] [Abstract][Full Text] [Related]
19. Treatment effects of immunomodulatory therapies at different stages of multiple sclerosis in short-term trials.
Bates D
Neurology; 2011 Jan; 76(1 Suppl 1):S14-25. PubMed ID: 21205678
[TBL] [Abstract][Full Text] [Related]
20. [The natural history of multiple sclerosis].
Confavreux C; Vukusic S
Rev Prat; 2006 Jun; 56(12):1313-20. PubMed ID: 16948219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
